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 2010 Elsevier Ltd. All rights reserved.Acid azides are synthetically extremely valuable compounds.
They form the starting materials for a vast range of reactions in or-
ganic synthesis as well as in peptides and peptidomimetic synthe-
sis. Acid azides are extensively used for the preparation of amides,
nitriles, and a variety of heterocycles through cycloaddition reac-
tions.1 Curtius rearrangement of acid azides into isocyanates is of
profound importance in organic synthesis as this can be used for
the preparation of amines, ureas, carbamates, amides, and many
other class of compounds.2 In peptide chemistry, acid azides occu-
py an important place wherein they form the building blocks for
peptide as well as peptidomimetic synthesis. They have been em-
ployed as coupling agents for the racemization-free formation of
peptide bond. These are also employed for the synthesis of peptide
mimics such as partially modiﬁed retro-inverso peptides, a/b-ure-
idopeptides, and amino acid derivatives like formamides and alkyl-
gem-diamines.3 The reactions of acid azides have been used to
advantage for the construction of a number of biologically valuable
compounds. In this regard, development of a new and improved
protocol for acid azide synthesis is signiﬁcant.
Acid azides are synthesized mainly through two routes (i) a
two-step protocol in which carboxylic acids are converted into sta-
ble reactive intermediates such as acid chlorides,4 acid hydra-
zides,5 and acyl benzotriazoles6 followed by their treatment with
azide ion. (ii) One-pot protocols with in situ activation of carbox-
ylic acids in the presence of azide ion. The former approach lacks
universal applications, for instance acid chloride and acid hydra-ll rights reserved.
86312937.
il.com, hariccb@hotmail.comzide methods are not compatible with substrates having acid and
base sensitive groups, respectively. Further, the acid chloride
method is constrained with respect to storage and stability aspects
due to the moisture sensitivity of certain acid chlorides. Also, the
poor solubility of NaN3 in organic medium requires phase transfer
catalysts, ZnI2/Zn triﬂate7 to obtain acceptable yields. Acid hydra-
zides have to be synthesized through a multistep process starting
from acids. In case of acyl benzotriazoles, the reaction duration is
prolonged. For the direct synthesis of acid azides from acids,
several types of activating agents have been employed, but many
of them possess certain intrinsic limitations. Some of these
reagents are toxic (triphosgene),8 irritating (SOCl2/DMF),9 expen-
sive [diphenylphosphoryl azide (DPPA), deoxoﬂour],10 while a
few other reagents produce undesirable by-products which are
difﬁcult to separate and toxic which in turn requires additional
handling costs and safety measures (i.e., cyanuric chloride,
tetramethylﬂouroformamidinium hexaﬂourophosphate, and phe-
nyl dichlorophosphate).11 Reagents like NCS–Ph3P and the recently
reported Cl3CCN–Ph3P12 have been employed, but the presence of
triphenyl phosphine unit in them disfavors the use of acid sensitive
reactants. The extensively employed mixed anhydride method13
suffers from the problem of isomerization in case of a,b-unsatu-
rated acids. Also, the mixed anhydride intermediates should be
generated by using chloroformates, which are corrosive and irri-
tants and harmful if inhaled, so pose handling problems.
Our group has described the ﬁrst synthesis of stable Na-Fmoc-
amino acid azides and demonstrated their application as peptide-
coupling agents. These acid azides were prepared via acid chloride
and mixed anhydride methods. Recently we also reported the
synthesis of acid azides using peptide-coupling agents EDC and
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Scheme 1. Synthesis of acid azides 1a–h.
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List of acid azides prepared via Schemes 1 and 2
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azides, we sought to develop a simple, alternative, and efﬁcient
protocol for the synthesis of these useful class of compounds.
T3P (propylphosphonic anhydride) is a highly reactive cyclic
anhydride, which has been employed for the conversion of carbox-
ylic acids, aldehydes, and amides to nitriles and formamides to iso-
nitriles. It has also been used in the preparation of heterocycles,
Weinreb amides, b-lactams, hydroxamic acids, thiohydroxamic
acid anhydrides, and in acylation reactions.15 It has been used as
a peptide-coupling agent, in the segment coupling and head to tail
cyclization of sterically hindered peptides.16 T3P offers several
advantages over other reagents in terms of higher yields, shorter
reaction duration, ease of isolation of the products, minimal side
reactions including epimerization during peptide couplings, inex-
pensive, and non-toxic nature. Based on these qualities, we sought
to develop a simple and efﬁcient method for the direct synthesis of
acid azides from carboxylic acids employing T3P.
A typical reaction was carried using benzoic acid as acid compo-
nent. A solution of benzoic acid and T3P in dry CH2Cl2 at 0 C was
treated with NaN3 in DMSO in the presence of Et3N. Carboxyl group
underwent activation by the T3P and readily reacted with the
azide ion to give corresponding benzoyl azide in 20 min in 92%
yield. The formation of acid azide was conﬁrmed by the presence
of a strong IR peak around mmax 2140–2144 cm1 and ﬁnally
through mass and NMR analyses. To explore the scope of this pro-
tocol, a series of aromatic acids substituted with electron-donating
as well as electron-withdrawing groups and long chain aliphatic
acids (hexanoic acid) were converted into corresponding acid
azides, 1a–h in good yield (Scheme 1).17 Table 1 summarizes the
results. In all these preparations, no column puriﬁcation was
needed, as the protocol did not result in the formation of contam-
inants and hence the acid azides could be isolated in pure form
through simple work-up.
The protocol was extended to prepare Na-Fmoc and Z-protected
amino acid azides from the corresponding Na-protected amino
acids.17 Several Fmoc-amino acid azides 2a–f including the side
chain protected amino acids (2b and 2c) were prepared and iso-
lated as solids (Scheme 2). In all the cases, the reaction proceeded
smoothly and rapidly with quantitative yield (Table 1). Z-Phe-N3
2g as well as the acid azide of Na-Z-Asp-oxazolidin-5-one 2h was
prepared similarly. Interestingly, when the unprotected Na-Fmoc-
serine was subjected to the above-mentioned reaction conditions,
the corresponding acid azide 2fwas obtained in good yield without
affecting the free hydroxyl group, despite the oxidation of alcohol
to aldehyde by T3P is known.15c The acid azide formation requires
about 20 min for completion while oxidation requires the treat-
ment of alcohol with T3P for overnight. Consequently, the synthe-
sis of Fmoc-Ser-N3 was possible.
Finally, the utility of T3P was applied for a three-step, one-pot
synthesis of ureidopeptides from Na-urethane protected amino
acids. The one-pot protocols are of paramount importance for rapid
synthesis of biologically active compounds and a large number of
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Comp. 
No.  
Pg R1 R2 Yield 
(%) 
3a Fmoc CH3 CH(CH3)2 92 
3b Fmoc H (CH2)3 88 
3c Z (CH2)3 CH2S(Bzl) 82 
3d Z CH2C6H5 CH(CH3)CH2
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3e Boc CH2CH(CH3)2 CH(CH3)2 80 
3f Boc C6H5 CH2C6H5 85 
Scheme 3. Synthesis of Na-urethane protected ureidopeptides 3a–f.
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peptides using Boc and Z-amino acids as reactants, the one-pot
protocols tend to furnish higher yields as the isolation of corre-
sponding unstable acid azides can be circumvented.
The Na-protected amino acid was converted to corresponding
acid azide in the presence of T3P/NaN3 in dry THF followed by
in situ Curtius rearrangement in toluene under ultrasonic condi-
tions into isocyanates. The transformation of acid azide into isocy-
anate in toluene under ultrasonic conditions was previously
reported by our group.2f The formation of isocyanate was con-
ﬁrmed through the appearance of IR peak at around mmax 2252–
2256 cm1. Further, to the solution of isocyanate, amino acid
methyl ester in dry CH2Cl2 was added and sonication was contin-
ued for an hour to obtain the corresponding ureidopeptide in good
yield. A series of ureidopeptides 3a–f were synthesized from Na-
Fmoc/Z/Boc amino acids.18 In case of Boc-protected amino acids,
an additional equivalent of base was used to avoid decrease in
the yield, possibly due to the acidic by-product liberated.The possibility of racemization during the synthesis of acid
azides and a-ureidopeptides via the present protocol was as-
sessed following the reported method, and it was found that
the protocol was racemization-free and yielded optically pure
products.19,20
In conclusion, we have described an alternative protocol for di-
rect conversion of acids to acid azides by employing T3P. A series
of carboxylic acids including Na-Fmoc/Z/Boc amino acids have
been converted to their acid azides. The utility of the reagent has
been extended for the one-pot synthesis of ureidopeptides. This
protocol is mild, high yielding, economical and eco-friendly. The
synthesis of acid azides as well as a-ureidopeptides via the present
protocol was proved racemization free.
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